Drug Trial Radar · NCT02859519
A Multi-centre, Double-blind, Randomized, Vehicle-controlled Study of Efficacy and Safety of Topical MOB015B in the Treatment of Mild to Moderate Distal Subungual Onychomycosis (DSO)
Last checked: Nov 19, 2026Latest source record: Dec 24, 2020 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
365
Actual
Start
Oct 2016
Primary completion
Nov 13, 2019
Study completion Nov 13, 2019
Sponsor
- Lead sponsor
- Moberg Pharma ABIndustry
- Sponsor type
- Industry
- First posted
- Aug 9, 2016
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 12 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The primary objective of this study is to evaluate the efficacy of topical MOB015B in patients with mild to moderate distal subungual onychomycosis (DSO). The secondary objective is to evaluate the safety of topical MOB015B in patients with mild to moderate DSO.
Conditions
- Distal Subungual Onychomycosis
Interventions
MOB015BDrug
MOB015B - Terbinafine hydrochloride (HCl) 10%, topical solution
MOB015B VehicleDrug
MOB015B Vehicle without the active ingredient Terbinafine
Primary outcomes
What the sponsor says the trial is designed to measure.
- Subjects with complete cure of the target toe nail at Week 52Time frame: Week 52
Locations
10 sites in 2 countries. Site status is shown where the registry gives one.
Site not named
Multiple Locations, California
Site not named
Multiple Locations, Florida
Site not named
Multiple Locations, Idaho
Site not named
Rolling Meadows, Illinois
Site not named
Fridley, Minnesota
Site not named
Multiple Locations, New Jersey
Site not named
Multiple Locations, Oregon
Site not named
Multiple Locations, Texas
Site not named
Multiple Locations, Virginia
Site not named
Multiple Locations, Canada
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.